Heart disease and stroke statistics—2023 update: a report from the American Heart Association
CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2023 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …
Pathophysiology and treatment of stroke: present status and future perspectives
D Kuriakose, Z Xiao - International journal of molecular sciences, 2020 - mdpi.com
Stroke is the second leading cause of death and a major contributor to disability worldwide.
The prevalence of stroke is highest in developing countries, with ischemic stroke being the …
The prevalence of stroke is highest in developing countries, with ischemic stroke being the …
Development of innovative biomaterials and devices for the treatment of cardiovascular diseases
Cardiovascular diseases have become the leading cause of death worldwide. The
increasing burden of cardiovascular diseases has become a major public health problem …
increasing burden of cardiovascular diseases has become a major public health problem …
Glial cells: role of the immune response in ischemic stroke
S Xu, J Lu, A Shao, JH Zhang, J Zhang - Frontiers in immunology, 2020 - frontiersin.org
Ischemic stroke, which accounts for 75–80% of all strokes, is the predominant cause of
morbidity and mortality worldwide. The post-stroke immune response has recently emerged …
morbidity and mortality worldwide. The post-stroke immune response has recently emerged …
Stroke risk factors, genetics, and prevention
AK Boehme, C Esenwa, MSV Elkind - Circulation research, 2017 - Am Heart Assoc
Stroke is a heterogeneous syndrome, and determining risk factors and treatment depends
on the specific pathogenesis of stroke. Risk factors for stroke can be categorized as …
on the specific pathogenesis of stroke. Risk factors for stroke can be categorized as …
Erectile dysfunction and diabetes: A melting pot of circumstances and treatments
G Defeudis, R Mazzilli, M Tenuta… - Diabetes/metabolism …, 2022 - Wiley Online Library
Diabetes mellitus (DM), a chronic metabolic disease characterised by elevated levels of
blood glucose, is among the most common chronic diseases. The incidence and prevalence …
blood glucose, is among the most common chronic diseases. The incidence and prevalence …
miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges
S Zhou, J Jin, J Wang, Z Zhang, JH Freedman… - Acta Pharmacologica …, 2018 - nature.com
Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality in the
world. Although considerable progress has been made in the diagnosis, treatment and …
world. Although considerable progress has been made in the diagnosis, treatment and …
Role of the ACE2/angiotensin 1–7 axis of the renin–angiotensin system in heart failure
Heart failure (HF) remains the most common cause of death and disability, and a major
economic burden, in industrialized nations. Physiological, pharmacological, and clinical …
economic burden, in industrialized nations. Physiological, pharmacological, and clinical …
Sedentary behavior and cardiovascular morbidity and mortality: a science advisory from the American Heart Association
Epidemiological evidence is accumulating that indicates greater time spent in sedentary
behavior is associated with all-cause and cardiovascular morbidity and mortality in adults …
behavior is associated with all-cause and cardiovascular morbidity and mortality in adults …
Lower rates of heart failure and all-cause hospitalizations during pulmonary artery pressure-guided therapy for ambulatory heart failure: one-year outcomes from the …
DM Shavelle, AS Desai, WT Abraham… - Circulation: Heart …, 2020 - Am Heart Assoc
Background: Ambulatory hemodynamic monitoring with an implantable pulmonary artery
(PA) sensor is approved for patients with New York Heart Association Class III heart failure …
(PA) sensor is approved for patients with New York Heart Association Class III heart failure …